Quick Comparison

Bacopa MonnieriReishi
Half-Life2-6 hours (bacosides)Bioactive compounds accumulate with daily use
Typical DosageStandard: 300-600 mg daily of extract standardized to 50% bacosides (e.g., Bacognize or Synapsa). Take with fat for absorption. Allow 8-12 weeks for full effects. Evening dosing preferred due to mild sedation.Standard: 1000-3000 mg daily of extract. Dual-extract (water + alcohol extraction) preferred to capture both polysaccharides and triterpenes. Take in the evening due to calming effects. Spore oil: 500-1000 mg daily. Effects build over 2-4 weeks.
AdministrationOral (capsules, powder). Fat-soluble — take with a meal containing fat.Oral (capsules, powder, tincture, tea). Dual-extract preferred. Bitter taste in powder/tea form.
Research Papers8 papers8 papers
Categories

Mechanism of Action

Bacopa Monnieri

Bacopa's bacosides (bacosides A and B, bacopaside I-VII) enhance synaptic communication by increasing dendritic branching, spine density, and synaptic activity in the hippocampus via modulation of neural cell adhesion molecules (NCAM) and FGF-2. They modulate serotonin through 5-HT3 receptor antagonism (reducing anxiety) and 5-HT2A modulation, dopamine through D1/D2 receptor modulation, and acetylcholine through enhancement of choline acetyltransferase. Bacosides upregulate tryptophan hydroxylase (TPH) and serotonin transporter (SERT) expression, increasing serotonin synthesis and reuptake. The antioxidant properties of bacosides reduce lipid peroxidation and protein carbonylation in the hippocampus via free radical scavenging, protecting neurons from oxidative damage during memory formation. They may enhance CREB phosphorylation and BDNF expression.

Reishi

Reishi's triterpenes (ganoderic acids A, C, D, H; ganoderenic acids) modulate the HPA axis by reducing CRH and ACTH release, lowering cortisol via glucocorticoid receptor feedback. Ganoderic acids have direct sedative effects through GABA-A receptor modulation (possibly allosteric at the benzodiazepine site) and 5-HT2A/2C serotonergic modulation. Beta-(1,3)-(1,6)-glucan polysaccharides bind Dectin-1 and complement receptor 3 (CR3) on macrophages, natural killer cells, and dendritic cells, activating NF-kB and MAPK signaling for immune modulation. Reishi inhibits histamine release from mast cells via Fc epsilon RI downregulation and stabilizes mast cell membranes (anti-allergic effect). Antioxidant properties involve upregulation of superoxide dismutase (SOD1/SOD2), catalase, and glutathione peroxidase. Ganoderic acids may also inhibit 5-alpha-reductase and ACE.

Risks & Safety

Bacopa Monnieri

Common

Gastrointestinal discomfort (cramping, nausea, bloating), fatigue, dry mouth.

Serious

May interact with thyroid medications.

Rare

Increased bowel movements, decreased appetite.

Reishi

Common

Digestive discomfort, dry mouth, dizziness.

Serious

Rare hepatotoxicity reported — avoid with liver disease. May interact with blood thinners and immunosuppressants.

Rare

Allergic reaction, nosebleeds.

Full Profiles